Raje NS - Search Results

1

Panaroni C, Yee AJ, Raje NS. Panaroni C, et al. Among authors: raje ns. Curr Osteoporos Rep. 2017 Oct;15(5):483-498. doi: 10.1007/s11914-017-0397-5. Curr Osteoporos Rep. 2017. PMID: 28861842 Review.

2

Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.

Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC. Chauhan D, et al. Blood. 1999 Mar 1;93(5):1482-6. Blood. 1999. PMID: 10029574 Free article.

3

Introduction: the evolving role of bisphosphonate therapy in multiple myeloma.

Raje N, Anderson KC. Raje N, et al. Blood. 2000 Jul 15;96(2):381-3. Blood. 2000. PMID: 10887095 Free article. Review. No abstract available.

4

Multiple myeloma.

Raje N, Anderson KC. Raje N, et al. Curr Treat Options Oncol. 2000 Apr;1(1):73-82. doi: 10.1007/s11864-000-0017-x. Curr Treat Options Oncol. 2000. PMID: 12057063 Review.

5

Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.

Tai YT, Li XF, Breitkreutz I, Song W, Neri P, Catley L, Podar K, Hideshima T, Chauhan D, Raje N, Schlossman R, Richardson P, Munshi NC, Anderson KC. Tai YT, et al. Cancer Res. 2006 Jul 1;66(13):6675-82. doi: 10.1158/0008-5472.CAN-06-0190. Cancer Res. 2006. PMID: 16818641 Free article.

6

Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.

Raje N, Hideshima T, Anderson KC. Raje N, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1239-47. doi: 10.1586/14737140.6.9.1239. Expert Rev Anticancer Ther. 2006. PMID: 17020458 Review.

7

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.

Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. Wang EP, et al. J Oral Maxillofac Surg. 2007 Jul;65(7):1328-31. doi: 10.1016/j.joms.2007.03.006. J Oral Maxillofac Surg. 2007. PMID: 17577497

8

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.

Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, Chhetri S, Pozzi S, Breitkreutz I, Kiziltepe T, Yasui H, Ocio EM, Shiraishi N, Jin J, Okawa Y, Ikeda H, Mukherjee S, Vaghela N, Cirstea D, Ladetto M, Boccadoro M, Anderson KC. Vallet S, et al. Blood. 2007 Nov 15;110(10):3744-52. doi: 10.1182/blood-2007-05-093294. Epub 2007 Aug 22. Blood. 2007. PMID: 17715391 Free PMC article.

9

Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma.

Breitkreutz I, Raab MS, Vallet S, Hideshima T, Raje N, Chauhan D, Munshi NC, Richardson PG, Anderson KC. Breitkreutz I, et al. Br J Haematol. 2007 Oct;139(1):55-63. doi: 10.1111/j.1365-2141.2007.06747.x. Br J Haematol. 2007. PMID: 17854307 Free article.

10

Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri S, Connell B, Xie W, Tai YT, Szot-Barnes A, Tian M, Schlossman RL, Weller E, Munshi NC, Van Den Abbeele AD, Anderson KC. Raje N, et al. Clin Cancer Res. 2008 Apr 15;14(8):2387-95. doi: 10.1158/1078-0432.CCR-07-1430. Clin Cancer Res. 2008. PMID: 18413829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters